Jeanny aragon-ching
WebJeanny B Aragon-Ching Maintenance therapy with immune checkpoint inhibitors (ICIs) has changed the treatment paradigm of metastatic urothelial carcinoma (mUC). The JAVELIN … WebDec 10, 2024 · Dr. Jeanny Aragon-ching graduated from Other in 1997. Dr. Aragon-ching has one office in Virginia where she specializes in Hematology / Oncology, Hematology …
Jeanny aragon-ching
Did you know?
WebJan 21, 2024 · Dr. Jeanny Aragon-Ching is the clinical program director of genitourinary cancers within the Inova Schar Cancer Institute. Dr. Jeanny B. Aragon-Ching has received an honoraria from Bristol-Myers Squibb. She has a consulting or advisory role with Algeta/Bayer, Dendreon, AstraZeneca, Janssen Biotech, and Sanofi. ... WebDr. Jeanny B. Aragon-Ching is an Internal Medicine Doctor in Fairfax, VA with special training and skill in the diagnosis, treatment, and care of adults across the spectrum from …
WebFeb 8, 2024 · Jeanny B. Aragon-Ching, MD, FACP Advanced Urothelial Carcinoma February 8, 2024 Dr. Aragon-Ching offers her thoughts on whether metastatic bladder cancer lends … WebMar 20, 2024 · Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. The doctors and researchers at the Inova ...
WebUse Muck Rack to listen to ARASENS, TRITON3, and Other Key Advances at GU23 by ASCO Daily News and connect with podcast creators. WebThe Best of NoVA, Straight to Your Inbox Sign-Up. Copyright © 2024 Northern Virginia Magazine
WebMar 4, 2024 · Plasmacytoid variant of urothelial carcinoma is a rare subtype of urothelial carcinoma that has poor prognosis. We describe two cases of patients with the plasmacytoid variant of urothelial carcinoma (PVUC) who had initial response to neoadjuvant chemotherapy followed by radical cystoprostatectomy and lymph node …
WebDr. Jeanny Aragon-Ching, MD is an Oncology Specialist in Fairfax, VA and has over 26 years of experience in the medical field. Dr. Aragon-Ching has extensive experience in Renal … fastway northeastWebJun 18, 2024 · Dr. Aragon-Ching is a medical oncologist and the clinical program director of the Genitourinary Oncology Program at the Inova Schar Cancer Institute in Virginia. Our full disclosures are available in the show … french white furniture for saleWebDr. Jeanny Aragon-Ching, Dr. Sam Lolak, and Lauren Broschak Page 2 of 6 very important part of the care of patients with bladder cancer, the overall psychosocial aspect of their care. With that I would like to turn to Dr. Lolak to further discuss these aspects. fastway northern ireland contact numberWebUroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology. fastway north sydneyWebNov 20, 2024 · Jeanny B. Aragon-Ching, MD, FACP Author Bios Disclosures Dr. Jeanny B. Aragon-Ching Article Highlights Apalutamide, enzalutamide, and darolutamide are all novel antiandrogens that have been shown to improve metastasis-free survival, and all are approved by the FDA for nmCRPC. french white houseWebAuthor Jeanny B Aragon-Ching 1 Affiliation 1GU Medical Oncology, Inova Schar Cancer Institute, Department of Medicine, Virginia Commonwealth University, Fairfax, VA. Electronic address: [email protected]. PMID: 28625477 DOI: 10.1016/j.urolonc.2024.05.023 Abstract fastway north east contact numberWebJeanny B. Aragon-Ching; Inger L. Rosner; Translational Andrology and Urology. Published on 01 Oct 2024. 0 views XX downloads; XX citations; 1760P Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Results from patients with ≥12 mo of treatment in JAVELIN Bladder 100. J.B. Aragon-Ching ... french white kitchen storage box